glp 1 agonist meds GLP-1 Agonists: A Comprehensive Overview Discovery of GLP-1–Based Drugs for
Description
The results of a recent national study conducted by the Arkansas Agricultural Experiment Station found that these weight loss drugs known as Glucagon-like peptide-1 agonists or GLP-1s lead to new food and drink consumption patterns, which underscore observed changes in food and beverage marketing
In the over 2500 participants, who were assigned to the 5, 10, and 15 mg doses of tirzepatide and placebo, the percent weight changes were both statistically and clinically significant compared with placebo
So, while Ozempic may (STILL) not have received the FDA's seal of approval for weight loss in non-diabetic patients, its hidden talent paved the way for Wegovy to step into the spotlight and take on a leading role in weight management
[6] Tirzepatide (Mounjaro): up to 15 mg once weekly for type 2 diabetes, and up to 15 mg once weekly for chronic weight management (marketed as Tirzepatide)
In addition, studies have linked GLP-1 receptor agonists to skeletal muscle breakdown
The result is significant weight loss
